The Journal of Organic Chemistry
Note
1H-tetrazole (73.1 mg, 0.500 mmol, 1.00 equiv), 3-amino-1-propanol
(0.101 mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-dimethyl)-
propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv) in EtOAc (4
mL). The crude mixture was purified by flash chromatography (50%
EtOAc/hexanes (300 mL), then 75% EtOAc/hexanes (300 mL)) to
separate the two tetrazole isomers. Tetrazole 10 (74.5 mg, 0.365
mmol, 73% yield) was isolated as a clear oil: Rf 0.56 (75% EtOAc/
hexanes); 1H NMR (500 MHz, CDCl3) δ 8.10−8.05 (m, 2H), 7.46−
7.39 (m, 3H), 4.78 (t, J = 6.9 Hz, 2H), 3.70 (t, J = 5.9 HZ, 2H),
3.31−3.25 (br.s., 1H), 2.25 (qn, J = 6.4 Hz, 2H); 13C{1H} NMR (125
MHz, CDCl3) δ 165.0, 130.4, 128.9, 127.2, 126.7, 58.7, 50.1, 31.9;
FTIR (cm−1) (neat) 3600−3200, 3200−2800, 1611, 1530, 1450,
1044; HRMS (ESI-TOF) m/z [M + H]+ calcd for C10H13N4O
205.1084, found 205.1082.
4-(5-Phenyl-2H-tetrazol-2-yl)butan-1-ol (11). The title compound
was prepared according to general procedure A using 5-phenyl-1H-
tetrazole (73.1 mg, 0.500 mmol, 1.00 equiv), 4-amino-1-butanol
(0.115 mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-dimethyl)-
propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv) in CHCl3 (4
mL). The crude mixture was purified by flash chromatography (50%
EtOAc/hexanes (300 mL), then 80% EtOAc/hexanes (300 mL)) to
separate the two tetrazole isomers. Tetrazole 11 (78.6 mg, 0.360
mmol, 72% yield) was isolated as a clear oil: Rf 0.46 (80% EtOAc/
hexanes); 1H NMR (500 MHz, CDCl3) δ 8.15−8.11 (m, 2H), 7.51−
7.43 (m, 3H), 4.70 (t, J = 7.0 Hz, 2H), 3.71 (t, J = 6.2 Hz, 2H), 2.17
(quint., J = 7.3 Hz, 2H), 1.84−1.76 (br.s., 1H), 1.68−1.60 (m, 2H);
13C{1H} NMR (125 MHz, CDCl3) δ 165.2, 130.4, 129.0, 127.5,
126.9, 61.9, 53.1, 29.4, 26.1; FTIR (cm−1) (neat) 3600−3200, 3100−
2800, 1469, 1536, 1609, 1062; HRMS (ESI-TOF) m/z [M + H]+
calcd for C11H15N4O 219.1240, found 219.1238.
sticky oil: Rf 0.37 (75% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ 8.37 (s, 1H), 8.27 (d, J = 7.8 Hz, 1H), 7.68 (d, J = 7.8 Hz,
1H), 7.58 (t, J = 7.8 Hz, 1H), 7.84 (t, J = 5.3 Hz, 2H), 4.08 (t, J = 5.3
Hz, 2H), 3.69−3.63 (m, 2H), 3.60−3.55 (m, 2H), 2.64 (t, J = 5.9 Hz,
1H); 13C{1H} NMR (100 MHz, CDCl3) δ 164.1, 131.5 (q, J = 32.8
Hz), 130.0 (d, J = 0.9 Hz), 129.6, 128.2, 127.0 (q, J = 3.7 Hz), 123.8
(q, J = 3.9 Hz), 123.9 (q, J = 272.4 Hz), 72.6, 68.2, 61.6, 53.2; 19F
NMR (375 MHz, CDCl3) δ −62.85 FTIR (cm−1) (neat) 3600−3200,
3200−2800, 1599, 1526, 1449, 1168, 1120, 1069; HRMS (ESI-TOF)
m/z [M + H]+ calcd for C12H13F3N4O2 303.1063, found 303.1070.
4-(2-Phenethyl-2H-tetrazol-5-yl)pyridine (15). The title com-
pound was prepared according to general procedure A using 5-(4-
pyridyl)-1H-tetrazole (73.6 mg, 0.500 mmol, 1.00 equiv), phenethyl-
amine (0.157 mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-dimethyl)-
propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv) in EtOAc (4
mL). The crude mixture was purified by flash chromatography (50%
EtOAc/hexanes (300 mL), then 80% EtOAc/hexanes (300 mL)) to
separate the two tetrazole isomers. Tetrazole 15 (106 mg, 0.422
mmol, 84% yield) was isolated as an off-white solid: Rf 0.38 (50%
EtOAc/hexanes); mp 60−69 °C; 1H NMR (400 MHz, CDCl3) δ 8.75
(d, J = 5.6 Hz, 2H), 7.99 (d, J = 5.6 Hz, 2H), 7.33−7.21 (m, 3H),
7.18 (d, J = 7.2 Hz, 2H), 4.90 (t, J = 7.6 Hz, 2H), 3.37 (t, J = 7.6 Hz,
2H); 13C{1H} NMR (100 MHz, CDCl3) δ 163.1, 150.7, 136.2, 134.8,
129.0, 128.7, 127.3, 120.8, 54.5, 35.7; FTIR (cm−1) (neat) 3200−
2800, 1611, 1497, 1457; HRMS (ESI-TOF) m/z [M + H]+ calcd for
C14H14N5 252.1244, found 252.1237.
3-(5-(5-Chlorothiophene-2-yl)-2H-tetrazol-2-yl)propan-1-ol (16).
The title compound was prepared according to general procedure A
using 5-(5-chloro-2-thienyl)-1H-tetrazole (93.3 mg, 0.500 mmol, 1.00
equiv), 3-amino-1-propanol (0.101 mL, 1.25 mmol, 2.50 equiv), and
1,3-(2,2-dimethyl)propanedinitrite (0.093 mL, 0.800 mmol, 1.60
equiv) in EtOAc (4 mL). The crude mixture was purified by flash
chromatography (50% EtOAc/hexanes (300 mL), then 75% EtOAc/
hexanes (300 mL)) to separate the two tetrazole isomers. Tetrazole
16 (93.0 mg, 0.380 mmol, 76% yield) was isolated as a pale-yellow oil:
2-(2-(5-Phenyl-2H-tetrazol-2-yl)ethoxy)ethan-1-ol (12). The title
compound was prepared according to general procedure A using 5-
phenyl-1H-tetrazole (73.1 mg, 0.500 mmol, 1.00 equiv), 2-(2-
aminoethoxy)ethanol (0.120 mL, 1.25 mmol, 2.50 equiv), and 1,3-
(2,2-dimethyl)propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv)
in EtOAc (4 mL). The crude mixture was purified by flash
chromatography (80% EtOAc/hexanes). Tetrazole 12 (98.4 mg,
0.420 mmol, 84% yield) was isolated as a clear oil: Rf 0.53 (100%
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.11−8.06 (m,
2H), 7.46−7.39 (m, 3H), 4.79 (t, J = 5.4 Hz, 2H), 4.02 (t, J = 5.4 Hz,
2H), 3.66−3.61 (m, 2H), 3.56−3.52 (m, 2H), 3.02−2.96 (br.s., 1H);
13C{1H} NMR (125 MHz, CDCl3) δ 165.1, 130.4, 128.9, 127.2,
1
Rf 0.52 (75% EtOAc/hexanes); H NMR (500 MHz, CDCl3) δ 7.49
(d, J = 3.9 Hz, 1H), 6.90 (d, J = 3.9 Hz, 1H), 4.75 (t, J = 6.9 Hz, 2H),
3.69 (t, J = 5.7 Hz, 2H), 3.02 (br s, 1H), 2.23 (qn, J = 6.4 Hz, 2H);
13C{1H} NMR (125 MHz, CDCl3) δ 160.2, 132.9, 127.4, 127.2,
127.1, 58.6, 50.2, 31.8; FTIR (cm−1) (neat) 3600−3200, 3200−2800,
1575, 1485, 1415, 1058, 1032, 1007; HRMS (ESI-TOF) m/z [M +
H]+ calcd for C8H10ClN4OS 245.0258, found 245.0262.
126.8, 72.5, 68.2, 61.4, 52.9; FTIR (cm−1) (neat) 3600−3200, 3200−
2800, 1611, 1530, 1450, 1175, 1124, 1046; HRMS (ESI-TOF) m/z
[M + H]+ calcd for C11H15N4O2 235.1190, found 235.1185.
2-(5-(4-Bromophenyl)-2H-tetrazol-2-yl)ethan-1-ol (13). The title
compound was prepared according to general procedure A using 5-(4-
bromophenyl)-1H-tetrazole (113 mg, 0.500 mmol, 1.00 equiv),
ethanolamine (0.081 mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-
dimethyl)propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv) in
EtOAc (4 mL). The crude mixture was purified by flash
chromatography (50% EtOAc/hexanes (300 mL), then 75%
EtOAc/hexanes (300 mL)) to separate the two tetrazole isomers.
Tetrazole 13 (109 mg, 0.405 mmol, 81% yield) was isolated as a white
crystalline solid: Rf 0.64 (75% EtOAc/hexanes); mp 125−127 °C; 1H
NMR (500 MHz, CDCl3) δ 7.95 (dt, J = 8.5 Hz, 2.1 Hz, 2H), 7.60
(dt, J = 8.4 Hz, 2.0 Hz, 2H), 4.79 (t, J = 5.0 Hz, 2H), 4.26−4.21 (m,
2H), 2.78 (t, J = 6.4 Hz, 2H); 13C{1H} NMR (125 MHz, CDCl3) δ
164.5, 132.3, 128.4, 126.1, 125.0, 60.5, 55.7; FTIR (cm−1) (neat)
3600−3200, 3200−2800, 1601, 1449, 1419, 1048, 1004; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C9H10BrN4O 269.0033, found
269.0036.
8-(5-(5-Chlorothiophene-2-yl)-2H-tetrazol-2-yl)octan-1-ol (17).
The title compound was prepared according to general procedure A
using 5-(4-bromophenyl)-1H-tetrazole (113 mg, 0.500 mmol, 1.00
equiv), 8-amino-1-octanol (189 mg, 1.25 mmol, 2.50 equiv), and 1,3-
(2,2-dimethyl)propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv)
in EtOAc (4 mL). The crude mixture was purified by flash
chromatography (40% EtOAc/hexanes (300 mL), then 50%
EtOAc/hexanes (300 mL)) to separate the two tetrazole isomers.
Tetrazole 17 (120 mg, 0.381 mmol, 76% yield) was isolated as a pale-
yellow oil: Rf 0.48 (50% EtOAc/hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.50 (d, J = 3.9 Hz, 1H), 6.90 (d, J = 3.9 Hz, 1H), 4.54 (t, J
= 7.2 Hz, 2H), 3.55 (t, J = 6.7 Hz, 2H), 2.38 (br.s., 1H), 1.96 (qn, J =
6.9 Hz, 2H), 1.53−1.44 (m, 2H), 1.34−1.21 (m, 8H); 13C{1H} NMR
(125 MHz, CDCl3) δ 160.1, 132.6, 127.6, 127.1, 126.9, 62.6, 53.3,
32.6, 29.2, 29.1, 28.8, 26.2, 25.6; FTIR (cm−1) (neat) 3600−3200,
3200−2800, 1576, 1486, 1034, 1007; HRMS (ESI-TOF) m/z [M +
H]+ calcd for C13H20ClN4OS 315.1041, found 315.1046.
2-Benzyl-5-methyl-2H-tetrazole (18). The title compound was
prepared according to general procedure B2 using acetonitrile (0.261
mL, 0.500 mmol, 1.00 equiv), dibutyltin oxide (18.7 mg, 0.075 mmol,
0.150 equiv), azidotrimethylsilane (0.986 mL, 0.750 mmol, 1.50
equiv), benzylamine (0.137 mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-
dimethyl)propanedinitrite (0.093 mL, 0.800 mmol, 1.60 equiv) in
toluene (4 mL, 1.5 mL for the first step + 2.5 mL for the second step).
The crude mixture was purified by flash chromatography (25%
EtOAc/hexanes (300 mL), then 60% EtOAc/hexanes (300 mL)) to
separate the two tetrazole isomers. Tetrazole 18 (47.0 mg, 0.270
mmol, 54% yield) was isolated as a clear oil: Rf 0.39 (25% EtOAc/
2-(2-(5-(3-(Trifluoromethyl)phenyl)-2H-tetrazol-2-yl)ethoxy)-
ethan-1-ol (14). The title compound was prepared according to
general procedure A using 5-(3-(trifluoromethyl)phenyl)-1H-tetrazole
(107 mg, 0.500 mmol, 1.00 equiv), 2-(2-aminoethoxy)ethanol (0.120
mL, 1.25 mmol, 2.50 equiv), and 1,3-(2,2-dimethyl)propanedinitrite
(0.093 mL, 0.800 mmol, 1.60 equiv) in EtOAc (4 mL). The crude
mixture was purified by flash chromatography (75% EtOAc/hexanes).
Tetrazole 14 (125 mg, 0.414 mmol, 83% yield) was isolated as a clear
E
J. Org. Chem. XXXX, XXX, XXX−XXX